Business Wire

IBC2015 Rising Stars: The Unmissable Free Event for Students and Young Professionals

28.8.2015 10:53 | Business Wire

Del

The IBC2015 Rising Stars Programme offers a new generation of students and young professionals the chance to experience the realities of the electronic media and entertainment industry. A free event, it provides a truly unique flavour of the workplace with an unrivalled array of business personalities who have been invited to inspire, educate and challenge those attending. Delegates are part of an amazing event which includes free entry to the fourteen exhibition halls; exclusive conference sessions tackling the topics that really matter to young professionals; exclusive networking opportunities and an invitation to the IBC Hackfest party.

Delegates will get to see and handle the latest technology and learn about how the industry is developing; meeting established, successful and highly influential industry figures, as well as some of the brightest and most ambitious young entrepreneurs working in the industry today. The Rising Stars Programme offers the chance to network and meet others in a similar position, as well as to gain inspiration from current Rising Stars who are already making their way in the business.

Highlights of the Rising Stars 2015 programme include:

VICE News the ‘News in a Flash’ Session

News delivery and consumption is changing dramatically and companies that redefine news as we know it will talk about how they experiment and innovate to create and deliver content that attracts audiences, enhances user experience and increases engagement. From VICE - the largest youth media company in the world - Head of Content and Creative Director of VICE Media Benelux, Perre van den Brink, will lead the discussion.

Craft Skills Masterclass with Scot Barbour

From concept to camera, light to lens, and stream to screen, delegates have the chance to learn from award-winning filmmaker Scot Barbour some of the vast array of methods, mediums and invaluable milestones that comprise the storytelling journey towards what he likes to call ‘the heart of hell.’

Digital Creators - The New Mainstream

As online stars are becoming more popular than mainstream celebrities, there is a growing demand for digital creators. The most popular can earn millions of dollars. In this exciting session Dutch YouTube stars David Harms and Nikkie de Jager explain their daily routines and share tips on creating content that wins subscribers.

In addition to the tailored Rising Stars programme designed to help young professionals further their career, delegates get access to What Caught My Eye sessions; Saturday and Sunday keynotes; the IBC Big Screen Experience and the latest blockbuster films; the IBC Future Zone, IBC Drone Zone, IBC Hackfest party and the IBC Awards Ceremony. There is also the option to join the Touch & Connect Online Community, where Rising Stars can have an expanding online presence within the electronic media and entertainment industry, keeping up to date with weekly topics, questions, interviews, competitions and the latest information.

IBC is one of the world's leading events focusing on the business of creating, managing and delivering the future of electronic media and entertainment technology and content. Featuring an influential conference and world-class exhibition, IBC annually immerses over 55,000 professionals from 170 countries in an unrivalled experience which provides the chance to trade and educate, to debate and connect, to challenge, strategise and innovate with the very companies and leaders shaping the market.

For further information and details of all that will be happening on this unmissable programme, please visit: www.ibc.org/RisingStars

## ENDS ##

Note to Editors:

About IBC

IBC is the premier annual event for professionals engaged in the creation, management and delivery of entertainment and news content worldwide. Attracting 55,000+ attendees from more than 170 countries, IBC combines a highly respected and peer-reviewed conference with an exhibition that exhibits more than 1,500 leading suppliers of state of the art electronic media technology and provides unrivalled networking opportunities.

For more information visit www.ibc.org

Find out more about the IBC Conference – www.ibc.org/conference

Find out more about the IBC Exhibition – www.ibc.org/discovermore

Find out more about IBC Content Everywhere – www.ibcCE.org

IBC2015 Dates:

Conference:       10 - 14 September 2015    
 
Exhibition: 11 - 15 September 2015

Contact information

IBC
Laura Olley
Marketing Manager
marketing@ibc.org
+44 (0) 207 832 4104

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom